相关实验视频
Updated: Jun 18, 2026

06:47
A Murine Model of Vertical Sleeve Gastrectomy
Published on: December 18, 2017
11.2K
从腹部外科手术到怀孕:优化胎儿体重的理想时间
Ana Carreira1, Bárbara Araújo2, Mariana Lavrador2,3
1Department of Endocrinology, Diabetes and Metabolism, Centro Hospitalar E Universitário de Coimbra, 3004-561, Coimbra, Portugal. 11720@chuc.min-saude.pt.
Obesity surgery
|July 22, 2023
概括
在减肥手术 (BS) 后至少等待24个月,可以显著降低怀孕年龄小 (SGA) 新生儿的风险. 较长的手术到怀孕间隔 (BSCI) 与出生体重增加和SGA风险降低有关.
科学领域:
- 产科和妇科 产科和妇科
- 腹部外科手术的结果
- 新生儿健康 新生儿健康
背景情况:
- 腹腔外科手术 (BS) 与妊娠年龄小 (SGA) 新生儿的风险增加有关.
- 目前的指导方针建议BS和受孕之间的间隔为12-24个月,但最佳时机尚不清楚.
研究的目的:
- 评估手术到怀孕间隔 (BSCI) 对新生儿出生体重和SGA风险的影响.
- 确定一个最佳的BSCI以减轻不良的新生儿结果.
主要方法:
- 追溯性对象研究42个怀孕后的腹腔外科手术.
- 如果新生儿出生时体重小于第10个百分点,则被归类为SGA.
- 进行ROC曲线分析,以确定最佳的BSCI切线.
主要成果:
- 在BSCI和出生体重 (每月增加4.5g) 之间发现了线性关联.
- BSCI和SGA风险之间的反向关联 (每月-6%).
- 24.5个月的BSCI被确定为最佳;24个月内怀孕的SGA风险增加了10倍以上 (OR12.6).
结论:
- 手术到怀孕间隔 (BSCI) 显著影响出生体重和SGA风险.
- 建议最低24个月的BSCI,以减少腹部手术后SGA新生儿的风险.
相关概念视频
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...

